1h Free Analyst Time
Global Neglected Tropical Disease Treatment Market: About this market
Speak directly to the analyst to clarify any post sales queries you may have.
Neglected tropical diseases are caused by pathogens such as parasites, bacteria, and virus. The neglected tropical disease treatment market considers the treatment of neglected tropical diseases using antiparasitic drugs, antibacterial drugs, and antiviral drugs. Our analysis also considers growth opportunities in Asia, North America, and ROW. In 2018, the antiparasitic drugs segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing prevalence of parasite-infected diseases will play a significant role in the antiparasitic drugs segment to maintain its market position. Also, our global neglected tropical disease treatment market report looks at factors such as initiatives to increase awareness and access to medicines for neglected tropical diseases, high morbidity rates, and increased funding in R&D. However, challenges associated with diagnosing neglected tropical diseases, challenges associated with drug discovery for neglected tropical diseases, and the increase in drug resistance may hamper the growth of the neglected tropical disease treatment industry over the forecast period.
Global Neglected Tropical Disease Treatment Market: Overview
Initiatives to increase awareness and access to medicines for neglected tropical diseases
The growing prevalence of neglected tropical diseases in tropical and subtropical countries has led many organizations across the world to increase awareness and to ensure easy availability of drugs for the treatment of such diseases. For instance, the Global Buruli Ulcer initiative by the World Health Organization (WHO) is aimed at improving awareness about Buruli ulcer disease. Several other organizations across the world are taking initiatives to improve the access of medicines, vaccines, and diagnostics for the treatment of neglected tropical diseases in low and middle-income countries. These developments are expected to drive the growth of the global neglected tropical disease treatment market size at a CAGR of almost 5% during the forecast period.
Development and approval of therapeutics for neglected tropical diseases
The high incidence of neglected tropical diseases such as dengue, lymphatic filariasis, trachoma, and leishmaniasis have encouraged researchers to focus on developing therapeutics for such diseases. For instance, researchers at the University Hospitals Cleveland Medical Center have developed a drug to treat patients with lymphatic filariasis. The drug is currently in Phase II of clinical trials. Many such advancements in drug development will aid in the treatment of many neglected tropical diseases and also fuel the market’s growth.
Competitive Landscape
With the presence of a few players, the global neglected tropical disease treatment market is fairly concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug manufacturers, that include Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novartis AG, and Pfizer Inc.
Also, the neglected tropical disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORKPART 15: EXPLORE
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Executive Summary
The following companies are recognised as the key players in the global neglected tropical disease treatment market: Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novartis AG, and Pfizer Inc.Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the development and approval of therapeutics for neglected tropical diseases.”
According to the report, one of the major drivers for this market is the initiatives to increase awareness and access to medicines for neglected tropical diseases.
Further, the report states that one of the major factors hindering the growth of this market is the challenges associated with diagnosing neglected tropical diseases.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Novartis AG
- Pfizer Inc.